M
Magnolia Medical Technologies
Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests
About Magnolia Medical Technologies
Magnolia Medical Technologies specializes in developing advanced medical devices aimed at improving the accuracy of blood culture tests. The company's flagship product, the Steripath Gen2, is FDA-cleared and designed to reduce blood culture contamination, which is crucial for accurate sepsis testing. Magnolia Medical serves healthcare providers and institutions, operating in the medical device market. The business model revolves around the sale of its proprietary devices, which are recognized for their innovation and effectiveness in infection prevention. Revenue is generated through direct sales and partnerships with healthcare facilities.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 81
- Open positions
- 11
- Dealroom signal
- 63.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Testing, Risk Management, Patient Care, Health Diagnostics, Spinout, medical testing, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Client focus
- B2C
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Feb 2022 | $46M | — | SightLine Partners · Sectoral Asset Management · HealthQuest Capital · RTW Investments | ↗ |
| DEBTDebt | May 2020 | $20M | — | Horizon Technology Finance Corporation | — |
Growth signals
Latest recorded traffic for Magnolia Medical Technologies is 6.5K monthly website visits, down 9.7% over the last three months. Magnolia Medical Technologies's team declined 4.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Magnolia Medical Technologies in the Seattle ecosystem
The Magnolia Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Rhapsody Venture Partners
HealthQuest Capital
Evidity Health Capital
Series B and later5 investors entered at this stage
RTW Investments
SightLine Partners
Horizon Technology Finance Corporation
Sectoral Asset Management- JHJanus Henderson
Other known investors1 additional known investor
University of Washington Medical Center
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Magnolia Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Magnolia Medical Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









